Advertisement

Topics

Nano-targeting treatment for prostate cancer

19:00 EST 12 Nov 2017 | AAAS

(American Association of Pharmaceutical Scientists) Metastatic or castrate-resistant prostate cancer can spread to the bone in certain patients. While several new treatments are available, they can have a difficult time reaching the bone and can result in missing the metastatic lesions. New research presented today at the 2017 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition seeks to address this challenge with the development of a bone-targeted nanoparticle (NP) that delivers the chemotherapy drug cabazitaxel directly to the bone.

Original Article: Nano-targeting treatment for prostate cancer

NEXT ARTICLE

More From BioPortfolio on "Nano-targeting treatment for prostate cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...